About: COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches
Creator	Liu, Lei Wang, Song Huang, Jia Qiu, Liping Cui, Xinping Liao, Jiayu Madahar, Vipul Way, George Xu, Zehui Ye, Fangfan Ye, Manhua Zeng, Manfei Zhai, Song Zhu, Tengfei
Source	MedRxiv
abstract	Various medical treatments for COVID-19 are attempted. After patients are discharged, SARS-CoV-2 recurring cases are reported and the recurrence could profoundly impact patient healthcare and social economics. To date, no data on the effects of medical treatments on recurrence has been published. We analyzed the treatment data of combinations of ten different drugs for the recurring cases in a single medical center, Shenzhen, China. A total of 417 patients were considered and 414 of them were included in this study (3 deaths) with mild-to-critical COVID-19. Patients were treated by 10 different drug combinations and followed up for recurrence for 28 days quarantine after being discharged from the medical center between February and May, 2020. We applied the Synthetic Minority Oversampling Technique (SMOTE) to overcome the rare recurring events in certain age groups and performed Virtual Twins (VT) analysis facilitated by random forest regression for medical treatment-recurrence classification. Among those drug combinations, Methylprednisolone/Interferon/Lopinavir/Ritonavir/Arbidol led to the lowest recurring rate (0.133) as compared to the average recurring rate (0.203). For the younger group (age 20-27) or the older group (age 60-70), the optimal drug combinations are different, but the above combination is still the second best. For obese patients, the combination of Ribavirin/Interferon/Lopinavir/Ritonavir/Arbidol led to the lowest recurring rate for age group of 20-50, whereas the combination of Interferon/Lopinavir/Ritonavir/Arbidol led to lowest recurring rate for age group of 50-70. The insights into combinatorial therapy we provided here shed lights on the use of a combination of (biological and chemical) anti-virus therapy and/or anti-cytokine storm as a potentially effective therapeutic treatment for COVID-19.
has issue date	2020-08-01(xsd:dateTime)
bibo:doi	10.1101/2020.07.29.20164699
has license	medrxiv
sha1sum (hex)	737dccffd711ad2000309f71bb802eede65c5735
schema:url	https://doi.org/10.1101/2020.07.29.20164699
resource representing a document's title	COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches
resource representing a document's body	covid:737dccffd711ad2000309f71bb802eede65c5735#body_text
is schema:about of	named entity 'days' named entity 'Synthetic Minority Oversampling Technique' named entity 'patients' named entity 'Determined' named entity 'DRUGS' named entity '414' named entity 'DEATHS' named entity 'DISCHARGED' named entity 'RIBAVIRIN' named entity 'RARE' named entity 'BEING' named entity 'COMBINATIONS' named entity 'DRUG COMBINATIONS' named entity 'LED' named entity 'TREATMENTS' named entity 'QUARANTINE' named entity 'MILD' named entity 'CASES' named entity 'STUDY' named entity 'chemical' named entity 'random forest' named entity 'Various' named entity 'total' named entity 'Shenzhen' named entity 'therapeutic' named entity 'biological' named entity 'medical treatments' named entity 'combination' named entity 'age' named entity 'drug' named entity 'patients' named entity 'compared' named entity 'medical' named entity 'Machine Learning' named entity 'obese' named entity 'Methylprednisolone' named entity 'random forest' named entity 'Arbidol' named entity 'COVID-19' named entity 'Combinatorial' named entity 'COVID-19' named entity 'peer review' named entity 'infection' named entity '21 days' named entity 'IFNa' named entity 'virus shedding' named entity 'statistical analysis' named entity 'preprint' named entity 'Ritonavir' named entity 'mixed infections' named entity 'Lopinavir' named entity 'Arbidol' named entity 'drug treatment' named entity 'cough' named entity 'statistical analysis' named entity 'transfection' named entity 'preprint' named entity 'SARS-CoV-2' named entity 'Arbidol' named entity 'Favipiravir' named entity 'death rate' named entity 'quarantine' named entity 'IFNa' named entity 'IFNa' named entity 'medRxiv' named entity 'viral infection' named entity 'asymptomatic' named entity 'peer review' named entity 'viruses' named entity 'preprint' named entity 'IFN' named entity 'treatment groups'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software